- Stocks
- Healthcare
- NYSE: PFE

Price (delayed)

$41.68

Market cap

$233.31B

P/E Ratio

20.94

Dividend/share

$1.54

EPS

$1.99

Enterprise value

$271.24B

Pfizer Inc. is an American multinational pharmaceutical corporation. It is one of the world's largest pharmaceutical companies and ranked 57 on the 2018 Fortune 500 list of the largest United

The quick ratio has grown by 47% YoY and by 13% from the previous quarter

PFE's debt is down by 24% YoY

Pfizer's net income has decreased by 30% YoY but it has increased by 15% QoQ

Pfizer's EPS has decreased by 30% YoY but it has increased by 15% from the previous quarter

The price to earnings (P/E) is 13% higher than the 5-year quarterly average of 18.5 and 11% higher than the last 4 quarters average of 18.8

The gross margin has contracted by 4.3% YoY and by 3.8% from the previous quarter

What are the main financial stats of PFE

Market
Valuations
Earnings

Shares outstanding

5.6B

Market cap

$233.31B

Enterprise value

$271.24B

Price to earnings (P/E)

20.94

Price to book (P/B)

3.39

Price to sales (P/S)

5.23

EV/EBIT

22.8

EV/EBITDA

16.26

EV/Sales

6.1

Revenue

$44.46B

EBIT

$11.9B

EBITDA

$16.68B

Free cash flow

$12.96B

Per share
Balance sheet
Liquidity

EPS

$1.99

Free cash flow per share

$2.32

Book value per share

$12.3

Revenue per share

$7.96

TBVPS

$14.52

Total assets

$158.82B

Total liabilities

$89.95B

Debt

$39.7B

Equity

$68.62B

Working capital

$12.88B

Debt to equity

0.58

Current ratio

1.48

Quick ratio

0.88

Net debt/EBITDA

2.27

Margins
Efficiency
Dividend

EBITDA margin

37.5%

Gross margin

76.3%

Net margin

24.9%

Operating margin

20.9%

Return on assets

6.6%

Return on equity

17%

Return on invested capital

11.6%

Return on capital employed

9%

Return on sales

26.8%

Dividend yield

3.69%

DPS

$1.54

Payout ratio

77.4%

How has the Pfizer stock price performed over time

Intraday

0.51%

1 week

3.3%

1 month

6.73%

1 year

8.51%

YTD

13.23%

QTD

6.44%

How have Pfizer's revenue and profit performed over time

Revenue

$44.46B

Gross profit

$33.94B

Operating income

$9.3B

Net income

$11.09B

Gross margin

76.3%

Net margin

24.9%

PFE's net margin is down by 40% YoY but it is up by 9% from the previous quarter

Pfizer's net income has decreased by 30% YoY but it has increased by 15% QoQ

The operating income has grown by 24% from the previous quarter

The company's operating margin rose by 17% QoQ

What is Pfizer's growth rate over time

What is Pfizer stock price valuation

P/E

20.94

P/B

3.39

P/S

5.23

EV/EBIT

22.8

EV/EBITDA

16.26

EV/Sales

6.1

Pfizer's EPS has decreased by 30% YoY but it has increased by 15% from the previous quarter

The price to earnings (P/E) is 13% higher than the 5-year quarterly average of 18.5 and 11% higher than the last 4 quarters average of 18.8

PFE's P/B is 13% above its last 4 quarters average of 3.0 and 2.7% above its 5-year quarterly average of 3.3

Pfizer's equity has increased by 9% QoQ and by 6% YoY

Pfizer's revenue has increased by 17% YoY and by 6% QoQ

PFE's P/S is 11% above its 5-year quarterly average of 4.7 and 4.6% above its last 4 quarters average of 5.0

How efficient is Pfizer business performance

Pfizer's ROS has decreased by 37% YoY but it has increased by 11% from the previous quarter

The company's return on invested capital fell by 36% YoY but it rose by 17% QoQ

The ROE fell by 32% YoY but it rose by 14% QoQ

Pfizer's ROA has decreased by 31% YoY but it has increased by 16% from the previous quarter

What is PFE's dividend history

DPS

$1.54

Dividend yield

3.69%

Payout ratio

77.4%

Recent dividends

How did Pfizer financials performed over time

PFE's total assets is 77% greater than its total liabilities

The quick ratio has grown by 47% YoY and by 13% from the previous quarter

The current ratio has grown by 44% YoY and by 10% from the previous quarter

PFE's debt is 42% less than its equity

The debt to equity has contracted by 28% YoY and by 8% from the previous quarter

PFE's debt is down by 24% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.